Stay updated on Study of bb2121 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Study of bb2121 in Multiple Myeloma Clinical Trial page.

Latest updates to the Study of bb2121 in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedA dedicated Locations section was added, listing California, Maryland, Massachusetts, Minnesota, New Jersey, New York, and Tennessee, and individual state location links were removed. The page revision was updated to v3.3.3 (replacing v3.3.2).SummaryDifference0.9%

- Check10 days agoChange DetectedThe page no longer displays 'Multiple Myeloma' and related topics such as 'MedlinePlus Genetics.' This removes context about the study's focus and related educational resources.SummaryDifference0.2%

- Check18 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page.SummaryDifference0.2%

- Check32 days agoChange DetectedPublications section wording updated to indicate entries are automatically filled from PubMed and may not be about the study, replacing the prior description.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding status banner and related operating status information from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check46 days agoChange DetectedThe study record's disease tag 'Multiple Myeloma' and related topic 'MedlinePlus Genetics' were removed from the page. This reduces disease-focused tagging and discoverability of the trial for users searching by these terms.SummaryDifference0.2%

Stay in the know with updates to Study of bb2121 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study of bb2121 in Multiple Myeloma Clinical Trial page.